OUR CAPABILITY

FACILITIES:

TAILORED TO YOUR TRADE & TRAITS

Pharmaniaga Manufacturing facilities provide a wide variety of possibilities in realising your products. With a signifi ant advantage in Active Pharmaceutical Ingredients (API) sourcing, we are able to cover all aspects of the process, from product development and clinical trials to commercial manufacturing. This enables efficient scale-up from development to commercial production. The integrated chain of processes allows us to recommend ways to improve production methods, reduce risks and improve efficiency.

OUR FACILITIES.

Wide array of Options for your best matched pharmaceutical manufacturing needs

Pharmaniaga Manufacturing Berhad, Selangor, Malaysia

General Pharma & Cephalosporin

Pharmaniaga LifeScience, Selangor, Malaysia

Small Volume Injectables

Idaman Pharma Manufacturing, Perak, Malaysia

Sterile and Non-Sterile Penicillin

Idaman Pharma Manufacturing, Kedah, Malaysia

General Pharma & Phytomedicine

Bio-Collagen Technologies, Selangor, Malaysia

Medical Devices

PT Errita Pharma, Bandung, Indonesia

General Pharma & Penicillin



Pharmaniaga Manufacturing Berhad, Selangor, Malaysia

General Pharma & Cephalosporin

Built in 1989, Pharmaniaga Manufacturing Berhad (PMB) has been manufacturing oral solid dosage forms. Aspired to become the supplier of choice for oral solid dosage, PMB is continuously investing in bigger capacity and state-of-the-art machines. This leads to the purchase of tablet compression machines which are able to achieve speeds ranging from 500,000 to 700,000 tablets per hour. The current capacity is at 2.8 billion tablets per annum. In recognition of its commitment to excellence, Pharmaniaga Manufacturing Berhad was announced the winner of the Prime Minister’s Quality Management Excellence Award and the winner of Gold Medal in Frost & Sullivan - Malaysia’s Manufacturing Excellence Awards.

PLANT HIGHLIGHTS

SOLID
  • 2,800,000,000 Tablets / year
  • 192,000,000 Capsules / year
  • 290,000 Bottles Dry Syrup / year

LIQUID
  • 12,000,000 Bottles Liquid / year
  • 4,000,000 Tubes Cream / year

CEPHALOSPORIN
  • 96,000,000 Tablets / year
  • 144,000,000 Capsules / year
  • 770,000 Vials / year

Pharmaniaga LifeScience, Selangor, Malaysia

Small Volume Injectables

Pharmaniaga LifeScience Sdn Bhd (PLS) is the only specialised sterile small volume injectable (SVI) plant in Malaysia. The facility was awarded with the European Union (EU) Good Manufacturing Practice (GMP) certificate in 2013 by Infarmed Portugal. The facility is able to produce SVI products ranging from 1ml to 20ml ampoules, and 2ml to 20ml vials with a batch capacity ranging from 30L to 1500L.

The quality control and microbiology laboratories are equipped with high-tech equipment such as a FTIR Spectrometer, an Atomic Absorption Spectrometer, Gas Chromatographs, High Performance Liquid Chromatographs and a Barrier Isolator for sterility testing. The plant has also been expanded to include one of the nation's first lyophiliser facilities.

PLANT HIGHLIGHTS

  • The first Malaysian pharmaceutical plant to receive the EU GMP certification.

  • Nominated as the “Exemplary Manufacturing Plant” during the 2013 National Pharmaceutical Control Bureau audit

Idaman Pharma Manufacturing, Perak, Malaysia

Sterile and Non-Sterile Penicillin

Idaman Pharma Manufacturing Sdn Bhd (IPMSB) plant in Seri Iskandar is dedicated to the production of penicillin, both sterile and non-sterile. The plant was officiated by Malaysian Prime Minister, Tun Dr Mahathir Mohamad in 1997. Standing on 15 acres of land with building occupancy of 5 acres, the plant is the largest Penicillin facility in Malaysia both in size and capacity. Operated by 230 workforce, the plant is capable of producing products in various dosage forms such as tablets, capsules, dry syrups and injectables.

PLANT HIGHLIGHTS

PENICILLIN
  • 97,000,000 Tablets / year
  • 128,000,000 Capsules / year
  • 2,700,000 Bottles Dry Syrup / year
  • 3,000,000 Vials / year

Idaman Pharma Manufacturing, Kedah, Malaysia

General Pharma & Phytomedicine

The Idaman Pharma Manufacturing Sdn Bhd (IPMSB) plant in Kedah manufactures tablets, capsules, dry syrups, syrups, suspensions, creams, lotions, solutions, ointments and ear drops. This plant is operated by 350 dedicated staff to meet every production requirements. The IPMSB plant in Kedah is among the first pharmaceutical plants in Malaysia to receive Halal certification.

PLANT HIGHLIGHTS

SOLID
  • 583,000,000 Tablets / year
  • 54,000,000 Capsules / year
  • 760,000 Bottles Dry Syrup / year

LIQUID
  • 15,500,00 Bottles Liquid / year
  • 15,000,000 Tubes Cream / year
  • 8,000,000 Bottles of Lotion & Solution / year
  • 1,800,000 Ointment / year
  • 580,000 Bottles Ear Drop / year

Bio-Collagen Technologies, Selangor, Malaysia

Medical Devices

Bio-Collagen Technologies Sdn Bhd (BCT) is a manufacturer of collagen-based medical devices for wound care management. BCT currently manufactures 4 products – collagen sheet, reconstituted collagen sheet, collagen particles and reconstituted collagen sponge primarily for the Malaysian market. These products are categorised as medical devices that can be used as prescribed by physicians for treating wounds, burns, skin grafts and other types of skin loss by providing a layer of cover that will act as a scaffold to enable new skin cells to grow. BCT also has fibrogel and bone implants in its new products pipeline. Supporting the National Biotechnology Policy, BCT aims to develop cutting edge wound care product, and to create novel collagen-based medical devices through innovative research and development.

PLANT HIGHLIGHTS

  • Bio-Nexus company status

  • The only company in Malaysia producing collagen-based products

  • 200,000 collagen-based sheets per year

PT Errita Pharma, Bandung, Indonesia

General Pharma & Penicillin

Established in 1975, the PT Errita Pharma plant in Bandung currently manufactures more than 60 generic pharmaceutical products at highly competitive price. Dosage forms include tablets, capsules, syrups, suspensions, creams, ointments for general pharma and tablets, capsules and dry syrups for penicillin.

PLANT HIGHLIGHTS

SOLID
  • 700,000,000 Tablets / year
  • 150,000,000 Capsules / year
  • 500,000,000 Strips / year

PENICILLIN
  • 500,000,000 Tablets / year
  • 40,000,000 Strips / year
  • 100,000,000 Capsules / year
  • 10,000,000 Bottles Dry Syrup / year

LIQUID
  • 20,000,000 Bottles Liquid / year
  • 28,000,000 Tubes Cream / year
  • 20,000,000 Tubes Lotion / year

Pharmaniaga Research Centre, Selangor, Malaysia

Research and Development Centre

Pharmaniaga Research Centre aims to bring new products to the market faster and more cost-effectively, by leveraging its interdisciplinary approach and capability that focus on developments, improvements and reengineering of current formulations and manufacturing processes. Our proven platform and talented scientist will continue to achieve the productivity gains that adhere to the highest quality, safety and efficacy standards in each and every product developed, while advancing into new areas of biotechnology that includes Biogenerics and Phytomedicines.

Pharmaniaga Research Centre’s Quality Control and Research & Development Laboratories are accredited to the ISO/IEC 17025 Laboratory Accreditation Scheme.

RESEARCH CAPABILITY HIGHLIGHTS

  • Intellectual property cell
  • Speciality product development
  • Lyophilised product development
  • Pre-formulation studies
  • Formulation development
  • Process development
  • Analytical development and validations
  • Product scale-up
  • Development Batch Production Facilities
  • Bioequivalence studies
  • Biogenerics and Phytomedicines